<Anchor> During the

night, the additional confirmers were in their 30s. Among them, there were more people from foreign countries for four consecutive days as you can see now than those who came from Korea. No matter how hard you try to fight, there are many prospects that such a confirmed person will continue to come out until a cure or vaccine is finally released. Today, the clinical trial of the Corona 19 vaccine has begun in Korea. Our reporter went to the first clinical trial site.

Reporter Nam Joo-hyun.

<Reporter> This

is the first clinical trial participant to receive Corona 19 vaccine in Korea.

[You will be a little sick. It's stiff.] The

general vaccine ends with an injection, but this vaccine requires one more step of applying electrical stimulation to the injection site.

[Park Wan-beom/Seoul National University Hospital Infectious Medicine Professor: Because it is a DNA vaccine, a'electroporation' process is needed to open the cell membrane. So, the injection is performed first, and then the electroporation process is continued.]

The first clinical trial for the Corona 19 vaccine in Korea is the DNA vaccine developed by Innobio of the United States.

In the US, clinical trials for MERS have been conducted to Phase 2, and safety has been verified to some extent.

Seoul National University Hospital plans to conduct clinical trials over a year in two stages, first, to check the safety of 40 healthy adults aged 19 to 50, and to increase the age range to 64, to check for toxicity and effectiveness.

The recruitment of 40 first-level participants through the hospital website has already been completed.

[The first participant in the Corona 19 vaccine clinical trial: I have a child. The child will be able to live in a corona-free world in the future, so it will help.] The

hospital plans to first give the vaccine to 5 people to determine whether the antibody is formed and the amount of the antibody, and then to the other 35.

(Video coverage: Kang Dong-cheol · Kim Yong-woo, video editing: Park Jin-hoon, screen source: Inovio Pharmaceutical Company) 

▶ Competition for Corona 19 vaccine development is fierce… When is inoculation possible?